Is Wall Street Just Too Optimistic on All Major Stocks Heading Toward 2027?
The year 2026 has faced many challenges in the economy and the stock market alike. It seems amazing that the...
Read moreDetailsThe year 2026 has faced many challenges in the economy and the stock market alike. It seems amazing that the...
Read moreDetailsMost investors love dividends. Here is why -- dividends have accounted for roughly one-third of the S&P 500's total return...
Read moreDetailsThe continual move towards artificial intelligence and agentic AI has created massive opportunities and wealth. It has also taken...
Read moreDetailsEveryone wants to earn more money. It's a natural instinct. And in the United States, that's just part of the...
Read moreDetailsThe year 2026 has been a wild year for investors. And the year isn't even half-way over. Gold and silver...
Read moreDetailsThe United States has taken several stakes in public companies in 2025. Some of the news has been received...
Read moreDetailsTandem Diabetes Care, Inc. (NASDAQ: TNDM) was last seen trading at $22.60, and its 52-week range of...
Read moreDetailsWith 2025 winding down, many investors are still looking for new ideas for their 2026 investing strategy. The biotech sector...
Read moreDetailsThere is no doubt that there has been explosive growth around artificial intelligence. Technology stocks tied to AI have generally...
Read moreDetailsIf you haven't started your financial positioning and planning, its' high time to get off your assets and get a...
Read moreDetails
Oggonomics delivers daily stock analysis, Wall Street analyst coverage, and no-nonsense market commentary for investors who think for themselves.
Learn more

Subscribe to our weekly newsletter below and keep up with Oggonomics articles.